Patricia Dauer

1.3k total citations · 1 hit paper
21 papers, 1.0k citations indexed

About

Patricia Dauer is a scholar working on Cancer Research, Oncology and Surgery. According to data from OpenAlex, Patricia Dauer has authored 21 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cancer Research, 7 papers in Oncology and 4 papers in Surgery. Recurrent topics in Patricia Dauer's work include Pancreatic and Hepatic Oncology Research (6 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Cancer Cells and Metastasis (4 papers). Patricia Dauer is often cited by papers focused on Pancreatic and Hepatic Oncology Research (6 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Cancer Cells and Metastasis (4 papers). Patricia Dauer collaborates with scholars based in United States. Patricia Dauer's co-authors include Sulagna Banerjee, Alice Nomura, Ashok K. Saluja, Vikas Dudeja, Vineet K. Gupta, Nikita Sharma, Santanu Banerjee, Sabita Roy, Joseph J. Dalluge and Bhuwan Giri and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Patricia Dauer

21 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Preeclampsia pathophysiology and adverse outcomes during pregnancy and postpartum

2023 61 citations Sydney Dautel, Sunitha Suresh et al. Frontiers in Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patricia Dauer United States	15	512	363	262	172	105	21	1.0k
Lijing Wang China	20	668 1.3×	178 0.5×	299 1.1×	182 1.1×	78 0.7×	66	1.2k
Yu Song China	20	535 1.0×	144 0.4×	328 1.3×	136 0.8×	139 1.3×	58	1.2k
Dan Chen China	18	873 1.7×	241 0.7×	332 1.3×	229 1.3×	50 0.5×	77	1.5k
Huan Xu China	22	638 1.2×	333 0.9×	376 1.4×	186 1.1×	112 1.1×	56	1.3k
Min Feng China	18	251 0.5×	240 0.7×	140 0.5×	177 1.0×	39 0.4×	31	803
Rosa Divella Italy	21	387 0.8×	390 1.1×	314 1.2×	104 0.6×	39 0.4×	38	1.2k
Meng Gu China	22	662 1.3×	235 0.6×	387 1.5×	116 0.7×	69 0.7×	94	1.2k
Hae‐Yun Jung South Korea	20	823 1.6×	505 1.4×	307 1.2×	268 1.6×	186 1.8×	31	1.5k
Li Lai United States	18	721 1.4×	217 0.6×	212 0.8×	98 0.6×	42 0.4×	43	1.2k
Xiaoqun Ye China	14	390 0.8×	180 0.5×	204 0.8×	78 0.5×	63 0.6×	42	848

Countries citing papers authored by Patricia Dauer

Since Specialization

Citations

This map shows the geographic impact of Patricia Dauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia Dauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia Dauer more than expected).

Fields of papers citing papers by Patricia Dauer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia Dauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia Dauer. The network helps show where Patricia Dauer may publish in the future.

Co-authorship network of co-authors of Patricia Dauer

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia Dauer. A scholar is included among the top collaborators of Patricia Dauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia Dauer. Patricia Dauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Blumencranz, Peter, Mehran Habibi, Steven C. Shivers, et al.. (2023). The Predictive Utility of MammaPrint and BluePrint in Identifying Patients with Locally Advanced Breast Cancer Who are Most Likely to Have Nodal Downstaging and a Pathologic Complete Response After Neoadjuvant Chemotherapy. Annals of Surgical Oncology. 30(13). 8353–8361. 6 indexed citations

Dautel, Sydney, et al.. (2023). Preeclampsia pathophysiology and adverse outcomes during pregnancy and postpartum. Frontiers in Medicine. 10. 1144170–1144170. 61 indexed citations breakdown →

Eddy, Adrian C., Augustine Rajakumar, Frank T. Spradley, et al.. (2023). Bioflavonoid luteolin prevents sFlt ‐1 release via HIF ‐1α inhibition in cultured human placenta. The FASEB Journal. 37(8). e23078–e23078. 8 indexed citations

Chung, Alice, Marissa K. Srour, Farnaz Dadmanesh, et al.. (2022). Identification of transcriptional changes with MammaPrint and BluePrint in early-stage breast cancer after neoadjuvant chemotherapy.. Journal of Clinical Oncology. 40(16_suppl). 585–585. 1 indexed citations

Reid, Sonya, Tuya Pal, Xiao‐Ou Shu, et al.. (2022). Whole transcriptomic analysis of HR+ breast cancer in Black women classified as basal-type by BluePrint.. Journal of Clinical Oncology. 40(16_suppl). 517–517. 2 indexed citations

Crozier, Jennifer A., Pat W. Whitworth, Patricia Dauer, et al.. (2021). High concordance of 70‐gene recurrence risk signature and 80‐gene molecular subtyping signature between core needle biopsy and surgical resection specimens in early‐stage breast cancer. Journal of Surgical Oncology. 125(4). 596–602. 7 indexed citations

Dauer, Patricia, Nikita Sharma, Vineet K. Gupta, et al.. (2019). ER stress sensor, glucose regulatory protein 78 (GRP78) regulates redox status in pancreatic cancer thereby maintaining “stemness”. Cell Death and Disease. 10(2). 132–132. 93 indexed citations

Sharma, Nikita, Vineet K. Gupta, Patricia Dauer, et al.. (2019). O-GlcNAc modification of Sox2 regulates self-renewal in pancreatic cancer by promoting its stability. Theranostics. 9(12). 3410–3424. 50 indexed citations

Dauer, Patricia & Ernst Lengyel. (2019). New Roles for Glycogen in Tumor Progression. Trends in cancer. 5(7). 396–399. 43 indexed citations

10.

Gupta, Vineet K., Nikita Sharma, Kousik Kesh, et al.. (2018). Metastasis and chemoresistance in CD133 expressing pancreatic cancer cells are dependent on their lipid raft integrity. Cancer Letters. 439. 101–112. 50 indexed citations

11.

Dauer, Patricia, Nikita Sharma, Vineet K. Gupta, et al.. (2018). GRP78‐mediated antioxidant response and ABC transporter activity confers chemoresistance to pancreatic cancer cells. Molecular Oncology. 12(9). 1498–1512. 35 indexed citations

12.

Dauer, Patricia, Xianda Zhao, Vineet K. Gupta, et al.. (2017). Inactivation of Cancer-Associated-Fibroblasts Disrupts Oncogenic Signaling in Pancreatic Cancer Cells and Promotes Its Regression. Cancer Research. 78(5). 1321–1333. 96 indexed citations

13.

McGinn, Olivia, Vineet K. Gupta, Patricia Dauer, et al.. (2017). Inhibition of hypoxic response decreases stemness and reduces tumorigenic signaling due to impaired assembly of HIF1 transcription complex in pancreatic cancer. Scientific Reports. 7(1). 7872–7872. 35 indexed citations

14.

Arora, Nivedita, Osama Alsaied, Patricia Dauer, et al.. (2017). Downregulation of Sp1 by Minnelide leads to decrease in HSP70 and decrease in tumor burden of gastric cancer. PLoS ONE. 12(2). e0171827–e0171827. 23 indexed citations

15.

Dauer, Patricia, Vineet K. Gupta, Olivia McGinn, et al.. (2017). Inhibition of Sp1 prevents ER homeostasis and causes cell death by lysosomal membrane permeabilization in pancreatic cancer. Scientific Reports. 7(1). 1564–1564. 27 indexed citations

16.

Nomura, Alice, Vineet K. Gupta, Patricia Dauer, et al.. (2017). NFκB-Mediated Invasiveness in CD133+ Pancreatic TICs Is Regulated by Autocrine and Paracrine Activation of IL1 Signaling. Molecular Cancer Research. 16(1). 162–172. 44 indexed citations

17.

Nomura, Alice, Kaustav Majumder, Bhuwan Giri, et al.. (2016). Inhibition of NF-kappa B pathway leads to deregulation of epithelial–mesenchymal transition and neural invasion in pancreatic cancer. Laboratory Investigation. 96(12). 1268–1278. 73 indexed citations

18.

Dauer, Patricia, et al.. (2016). Microenvironment in determining chemo-resistance in pancreatic cancer: Neighborhood matters. Pancreatology. 17(1). 7–12. 115 indexed citations

19.

Banerjee, Santanu, Gregory M. Sindberg, Fuyuan Wang, et al.. (2016). Opioid-induced gut microbial disruption and bile dysregulation leads to gut barrier compromise and sustained systemic inflammation. Mucosal Immunology. 9(6). 1418–1428. 206 indexed citations

20.

Nomura, Alice, Patricia Dauer, Vineet K. Gupta, et al.. (2016). Microenvironment mediated alterations to metabolic pathways confer increased chemo-resistance in CD133+ tumor initiating cells. Oncotarget. 7(35). 56324–56337. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact